Clinical evaluation of Nomilen preparation containing Ca, Mg and P.
D000818:Animals; D002118:Calcium / Q000627:therapeutic use*; D002128:Calcium Metabolism Disorders / Q000188:drug therapy / Q000662:veterinary*; D002417:Cattle; D002418:Cattle Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004283:Dog Diseases / Q000188:drug therapy; D004285:Dogs; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D005994:Glycerophosphates / Q000627:therapeutic use*; D006041:Goats; D008274:Magnesium / Q000627:therapeutic use*; D010319:Parturient Paresis / Q000188:drug therapy*; D010760:Phosphorus Metabolism Disorders / Q000188:drug therapy / Q000662:veterinary*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000662:veterinary*; D012459:Salicylates / Q000627:therapeutic use*; D013552:Swine; D013553:Swine Diseases / Q000188:drug therapy
D004338:Drug Combinations; D005994:Glycerophosphates; D012459:Salicylates; C036187:Nomilen; D008274:Magnesium; D002118:Calcium